Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/04/20/3276770/0/en/novo-nordisk-etavopivat-is-the-first-in-a-new-class-of-drugs-to-meet-both-co-primary-endpoints-in-the-phase-3-hibiscus-trial-substantially-reducing-vaso-occlusive-crisis-events-and.html

GLOBENEWSWIRE
20 Apr 2026

https://www.businesswire.com/news/home/20211211005010/en

BUSINESSWIRE
11 Dec 2021

https://www.businesswire.com/news/home/20211104005291/en

BUSINESSWIRE
04 Nov 2021